Where does Canary Medical Switzerland AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Canary Medical Switzerland AG ranks #22,334 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Canary Medical Switzerland AG hold?

Canary Medical Switzerland AG holds 12 US utility patents granted between 2022 and 2025, spanning 9 technology areas.

What is Canary Medical Switzerland AG's Innovation Score?

Canary Medical Switzerland AG has an Innovation Score of 47.9 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Canary Medical Switzerland AG focus on?

Canary Medical Switzerland AG's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Canary Medical Switzerland AG's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Canary Medical Switzerland AG.

What does claim depth mean for Canary Medical Switzerland AG's patents?

Canary Medical Switzerland AG's patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Canary Medical Switzerland AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Canary Medical Switzerland AG

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Canary ranks #22,334 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#22,334
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.9/100): 14.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22334 · Foreign Corporation #22,334 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #22,334/49,997
PHOTO-FINISH Caldera Medical
CPC-NARROW A61B · 9 areas
INNOV-PAR 47.9/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Caldera Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Canary’s 47.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (19%) Velocity 20.0 pts (42%) Breadth 10.6 pts (22%) Claim depth 8.4 pts (18%)

Qualcomm Incorporated · highest

85
Canary Medical… · this assignee

48
3D Lighting… · lowest

7

What this shows Canary's Innovation Score is 47.9/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Canary?

Each dot is one of Canary’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Canary’s own 14.0 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Canary vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Canary's grants concentrate

Canary Medical Switzerland AG is a focused PatentsView assignee: 9 CPC subclasses with 91.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2023. By volume, Canary sits between CU Aerospace, LLC and Carlisle Intangible, LLC.

Canary's three-year grant acceleration

Canary Medical Switzerland AG shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

CU Aerospace

12
Culligan Internat…

12
Caldera Medical

12
California Cooper…

12
Carmax Enterprise…

12
Cardea Bio

12
Caret Holdings

12
Carlisle Intangib…

12
Canary Medical Sw… ◀

12

What this shows Canary holds 12 patents at rank #22,384, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Canary

By rank, the assignees closest to #22,384 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Canary's primary technology class.

Canary's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Canary Medical Switzerland AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	2	16.7%
2023	1	8.3%
2024	5	41.7%
2025partial year	4	33.3%

Which technologies does Canary Medical Switzerland AG patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A43B - Characteristic Features OF FOOTWEAR; Parts OF Footwear 1

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Canary Medical Switzerland AG's patent record in context - here's where to go next.

Canary Medical Switzerland AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 91.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #22,334 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Canary Medical Switzerland AG against CU Aerospace, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.